New York State Common Retirement Fund’s GenMark Diagnostics, Inc GNMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-62,000
| Closed | -$1.48M | – | 3616 |
|
|
2021
Q1 | $1.48M | Sell |
62,000
-57,130
| -48% | -$1.06M | ﹤0.01% | 1943 |
|
|
2020
Q4 | $1.74M | Sell |
119,130
-164,979
| -58% | -$2.19M | ﹤0.01% | 1756 |
|
|
2020
Q3 | $4.03M | Hold |
284,109
| – | – | ﹤0.01% | 1249 |
|
|
2020
Q2 | $4.18M | Buy |
284,109
+237,709
| +512% | +$2.42M | 0.01% | 1232 |
|
|
2020
Q1 | $191K | Hold |
46,400
| – | – | ﹤0.01% | 2482 |
|
|
2019
Q4 | $223K | Hold |
46,400
| – | – | ﹤0.01% | 2693 |
|
|
2019
Q3 | $281K | Hold |
46,400
| – | – | ﹤0.01% | 2604 |
|
|
2019
Q2 | $301K | Hold |
46,400
| – | – | ﹤0.01% | 2627 |
|
|
2019
Q1 | $329K | Hold |
46,400
| – | – | ﹤0.01% | 2493 |
|
|
2018
Q4 | $226K | Hold |
46,400
| – | – | ﹤0.01% | 2655 |
|
|
2018
Q3 | $341K | Hold |
46,400
| – | – | ﹤0.01% | 2591 |
|
|
2018
Q2 | $296K | Hold |
46,400
| – | – | ﹤0.01% | 2687 |
|
|
2018
Q1 | $252K | Hold |
46,400
| – | – | ﹤0.01% | 2642 |
|
|
2017
Q4 | $193K | Sell |
46,400
-426,867
| -90% | -$2.57M | ﹤0.01% | 2771 |
|
|
2017
Q3 | $4.56M | Hold |
473,267
| – | – | 0.01% | 1269 |
|
|
2017
Q2 | $5.6M | Buy |
473,267
+94,259
| +25% | +$1.21M | 0.01% | 1218 |
|
|
2017
Q1 | $4.86M | Buy |
379,008
+2,401
| +0.6% | +$28.9K | 0.01% | 1271 |
|
|
2016
Q4 | $4.61M | Hold |
376,607
| – | – | 0.01% | 1282 |
|
|
2016
Q3 | $4.44M | Sell |
376,607
-7,141
| -2% | -$68.9K | 0.01% | 1273 |
|
|
2016
Q2 | $3.34M | Hold |
383,748
| – | – | ﹤0.01% | 1397 |
|
|
2016
Q1 | $2.02M | Buy |
383,748
+8,829
| +2% | +$49.1K | ﹤0.01% | 1578 |
|
|
2015
Q4 | $2.91M | Hold |
374,919
| – | – | ﹤0.01% | 1453 |
|
|
2015
Q3 | $2.95M | Sell |
374,919
-1,426
| -0.4% | -$13.2K | ﹤0.01% | 1425 |
|
|
2015
Q2 | $3.41M | Buy |
376,345
+86,868
| +30% | +$876K | 0.01% | 1566 |
|
|
2015
Q1 | $3.76M | Hold |
289,477
| – | – | 0.01% | 1357 |
|
|
2014
Q4 | $3.94M | Buy |
289,477
+86,141
| +42% | +$963K | 0.01% | 1323 |
|
|
2014
Q3 | $1.82M | Hold |
203,336
| – | – | ﹤0.01% | 1654 |
|
|
2014
Q2 | $2.75M | Hold |
203,336
| – | – | ﹤0.01% | 1532 |
|
|
2014
Q1 | $2.02M | Hold |
203,336
| – | – | ﹤0.01% | 1645 |
|
|
2013
Q4 | $2.71M | Buy |
203,336
+66,698
| +49% | +$810K | ﹤0.01% | 1498 |
|
|
2013
Q3 | $1.66M | Buy |
+136,638
| New | +$1.46M | ﹤0.01% | 1625 |
|
New York State Common Retirement Fund's GNMK Position: Q2 2021 in Review
New York State Common Retirement Fund sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 62,000 shares — an estimated $1.48M sold.
New York State Common Retirement Fund first reported a position in GNMK in Q3 2013 and held it in 31 quarters. The position peaked at $5.6M in Q2 2017. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.
- New York State Common Retirement Fund reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
- New York State Common Retirement Fund sold 62,000 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $1.48M.
- New York State Common Retirement Fund first reported a position in GenMark Diagnostics, Inc in Q3 2013 and held it in 31 quarters.
- New York State Common Retirement Fund's GenMark Diagnostics, Inc position peaked at $5.6M in Q2 2017.
- 0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.
Based on New York State Common Retirement Fund's 13F filing for Q2 2021, filed 2 Aug 2021.